A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded ...
Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...
Business Insider on MSN7d
The FDA is about to make weight-loss drugs a lot harder to getLots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
The U.S. Drug Enforcement Agency (DEA) announced on Jan. 16, 2025, three new rules intended to implement patient protections and permanently ...
On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for ...
PanopticAI, a leading innovator in remote patient monitoring, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its contactless vital signs ...
The three states argue that relaxed FDA rules on mifepristone, such as allowing telehealth prescriptions, undermine their abortion laws and enforcement efforts. This case follows a U.S. Supreme ...
The states want the federal Food and Drug Administration to prohibit telehealth prescriptions for ... doctors and organizations that wanted the FDA to be forced to rescind entirely its approval ...
The states want the federal Food and Drug Administration to prohibit telehealth prescriptions for mifepristone ... a group of anti-abortion doctors and organizations that wanted the FDA to be forced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback